Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis

Jinping Liang, Xindong Teng, Xuefeng Yuan, Ying Zhang, Chunwei Shi, Tingting Yue, Lei Zhou, Jianrong Li, Xionglin Fan

Research output: Contribution to journalArticle

Abstract

Although Bacillus Calmette-Guérin (BCG) vaccine confers protection from Mycobacterium tuberculosis infection in children, its immune protection gradually wanes over time, and consequently leads to an inability to prevent the reactivation of latent infection of M. tuberculosis. Therefore, improving BCG for better control of tuberculosis (TB) is urgently needed. We thus hypothesized that recombinant BCG overexpressing immunodominant antigens expressed at different growth stages of M. tuberculosis could provide a more comprehensive protection against primary and latent M. tuberculosis infection. Here, a novel cocktail of recombinant BCG (rBCG) strains, namely ABX, was produced by combining rBCG::85A, rBCG::85B, and rBCG::X, which overexpressed respective multistage antigens Ag85A, Ag85B, and HspX of M. tuberculosis. Our results showed that ABX was able to induce a stronger immune protection than individual rBCGs or BCG against primary TB infection in C57BL/6 mice. Mechanistically, the immune protection was attributed to stronger antigen-specific CD4+ Th1 responses, higher numbers of IFN-γ+ CD4+ TEM and IL-2+ CD8+ TCM cells elicited by ABX. These findings thus provide a novel strategy for the improvement of BCG efficacy and potentially a promising prophylactic TB vaccine candidate, warranting further investigation.

Original languageEnglish (US)
Pages (from-to)392-401
Number of pages10
JournalMolecular Immunology
Volume66
Issue number2
DOIs
StatePublished - 2015

Fingerprint

Bacillus
Mycobacterium tuberculosis
Mycobacterium bovis
Tuberculosis
Tuberculosis Vaccines
Latent Tuberculosis
BCG Vaccine
Immunodominant Epitopes
CD4 Antigens
Mycobacterium Infections
Mycobacterium
Infection
Inbred C57BL Mouse
Interleukin-2
Mycobacterium tuberculosis antigens
Antigens
Growth

Keywords

  • Ag85 complex
  • HspX
  • Mycobacterium tuberculosis
  • Recombinant BCG
  • Tuberculosis
  • Vaccine

ASJC Scopus subject areas

  • Molecular Biology
  • Immunology
  • Medicine(all)

Cite this

Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis. / Liang, Jinping; Teng, Xindong; Yuan, Xuefeng; Zhang, Ying; Shi, Chunwei; Yue, Tingting; Zhou, Lei; Li, Jianrong; Fan, Xionglin.

In: Molecular Immunology, Vol. 66, No. 2, 2015, p. 392-401.

Research output: Contribution to journalArticle

Liang, Jinping ; Teng, Xindong ; Yuan, Xuefeng ; Zhang, Ying ; Shi, Chunwei ; Yue, Tingting ; Zhou, Lei ; Li, Jianrong ; Fan, Xionglin. / Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis. In: Molecular Immunology. 2015 ; Vol. 66, No. 2. pp. 392-401.
@article{8489915a7d194d93805d0429962b3eea,
title = "Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis",
abstract = "Although Bacillus Calmette-Gu{\'e}rin (BCG) vaccine confers protection from Mycobacterium tuberculosis infection in children, its immune protection gradually wanes over time, and consequently leads to an inability to prevent the reactivation of latent infection of M. tuberculosis. Therefore, improving BCG for better control of tuberculosis (TB) is urgently needed. We thus hypothesized that recombinant BCG overexpressing immunodominant antigens expressed at different growth stages of M. tuberculosis could provide a more comprehensive protection against primary and latent M. tuberculosis infection. Here, a novel cocktail of recombinant BCG (rBCG) strains, namely ABX, was produced by combining rBCG::85A, rBCG::85B, and rBCG::X, which overexpressed respective multistage antigens Ag85A, Ag85B, and HspX of M. tuberculosis. Our results showed that ABX was able to induce a stronger immune protection than individual rBCGs or BCG against primary TB infection in C57BL/6 mice. Mechanistically, the immune protection was attributed to stronger antigen-specific CD4+ Th1 responses, higher numbers of IFN-γ+ CD4+ TEM and IL-2+ CD8+ TCM cells elicited by ABX. These findings thus provide a novel strategy for the improvement of BCG efficacy and potentially a promising prophylactic TB vaccine candidate, warranting further investigation.",
keywords = "Ag85 complex, HspX, Mycobacterium tuberculosis, Recombinant BCG, Tuberculosis, Vaccine",
author = "Jinping Liang and Xindong Teng and Xuefeng Yuan and Ying Zhang and Chunwei Shi and Tingting Yue and Lei Zhou and Jianrong Li and Xionglin Fan",
year = "2015",
doi = "10.1016/j.molimm.2015.04.017",
language = "English (US)",
volume = "66",
pages = "392--401",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis

AU - Liang, Jinping

AU - Teng, Xindong

AU - Yuan, Xuefeng

AU - Zhang, Ying

AU - Shi, Chunwei

AU - Yue, Tingting

AU - Zhou, Lei

AU - Li, Jianrong

AU - Fan, Xionglin

PY - 2015

Y1 - 2015

N2 - Although Bacillus Calmette-Guérin (BCG) vaccine confers protection from Mycobacterium tuberculosis infection in children, its immune protection gradually wanes over time, and consequently leads to an inability to prevent the reactivation of latent infection of M. tuberculosis. Therefore, improving BCG for better control of tuberculosis (TB) is urgently needed. We thus hypothesized that recombinant BCG overexpressing immunodominant antigens expressed at different growth stages of M. tuberculosis could provide a more comprehensive protection against primary and latent M. tuberculosis infection. Here, a novel cocktail of recombinant BCG (rBCG) strains, namely ABX, was produced by combining rBCG::85A, rBCG::85B, and rBCG::X, which overexpressed respective multistage antigens Ag85A, Ag85B, and HspX of M. tuberculosis. Our results showed that ABX was able to induce a stronger immune protection than individual rBCGs or BCG against primary TB infection in C57BL/6 mice. Mechanistically, the immune protection was attributed to stronger antigen-specific CD4+ Th1 responses, higher numbers of IFN-γ+ CD4+ TEM and IL-2+ CD8+ TCM cells elicited by ABX. These findings thus provide a novel strategy for the improvement of BCG efficacy and potentially a promising prophylactic TB vaccine candidate, warranting further investigation.

AB - Although Bacillus Calmette-Guérin (BCG) vaccine confers protection from Mycobacterium tuberculosis infection in children, its immune protection gradually wanes over time, and consequently leads to an inability to prevent the reactivation of latent infection of M. tuberculosis. Therefore, improving BCG for better control of tuberculosis (TB) is urgently needed. We thus hypothesized that recombinant BCG overexpressing immunodominant antigens expressed at different growth stages of M. tuberculosis could provide a more comprehensive protection against primary and latent M. tuberculosis infection. Here, a novel cocktail of recombinant BCG (rBCG) strains, namely ABX, was produced by combining rBCG::85A, rBCG::85B, and rBCG::X, which overexpressed respective multistage antigens Ag85A, Ag85B, and HspX of M. tuberculosis. Our results showed that ABX was able to induce a stronger immune protection than individual rBCGs or BCG against primary TB infection in C57BL/6 mice. Mechanistically, the immune protection was attributed to stronger antigen-specific CD4+ Th1 responses, higher numbers of IFN-γ+ CD4+ TEM and IL-2+ CD8+ TCM cells elicited by ABX. These findings thus provide a novel strategy for the improvement of BCG efficacy and potentially a promising prophylactic TB vaccine candidate, warranting further investigation.

KW - Ag85 complex

KW - HspX

KW - Mycobacterium tuberculosis

KW - Recombinant BCG

KW - Tuberculosis

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84938829620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938829620&partnerID=8YFLogxK

U2 - 10.1016/j.molimm.2015.04.017

DO - 10.1016/j.molimm.2015.04.017

M3 - Article

C2 - 25974877

AN - SCOPUS:84938829620

VL - 66

SP - 392

EP - 401

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

IS - 2

ER -